Tech-TYA: eHealth Platform to Deliver Group Intervention for YA Cancer Survivors

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

7 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-06-09

Study Completion Date

2023-04-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to adapt a web-based platform to deliver a group intervention for young adult cancer survivors.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Digital Connections: an EHealth Group Intervention for Young Adult Cancer Survivors

NCT05952492

Cancer

COMPLETED NA

Study to Develop a Group-Based E-Health Intervention for YA Cancer Survivors

NCT05048316

Cancer Survivor Young Adult

COMPLETED NA

The HEALS Project - Health Education and Active Living for Surviving Seniors

NCT01305044

Cancer Survivorship Safety and Efficacy Quality of Life

COMPLETED PHASE2

A Mobile Phone Intervention to Promote Adherence to Survivorship Care Among Adolescent and Young Adult Cancer Survivors

NCT05000359

Survivors of Childhood Cancer

WITHDRAWN EARLY_PHASE1

mHealth for Young Adult Cancer Survivors

NCT05905250

Survivorship Cancer Psychological Well-Being

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In the first part of this study, the investigators adapted a website to deliver an evidence-based intervention for improving HRQOL for young adult cancer survivors, and then conducted usability testing sessions with young adult cancer survivors to get feedback on the website. In the second part of the study, the investigators will conduct a single-arm pilot trial in which the website will be used to deliver the intervention via weekly group meetings with a trained facilitator over the course of 10 weeks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Behavioral: Cognitive-Behavioral Stress Management and Health Education

Weekly video conference groups led by a trained facilitator

Group Type EXPERIMENTAL

Cognitive-Behavioral Stress Management and Health Education

Intervention Type BEHAVIORAL

Participants will attend group sessions with a trained facilitator held over videoconference. Sessions will each last 2 hours and be held once weekly for 10 weeks. Sessions will include Cognitive-Behavioral Stress Management and health education content.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cognitive-Behavioral Stress Management and Health Education

Participants will attend group sessions with a trained facilitator held over videoconference. Sessions will each last 2 hours and be held once weekly for 10 weeks. Sessions will include Cognitive-Behavioral Stress Management and health education content.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Aged 18-39 years at the time of participation
2. Diagnosed with a primary cancer between 18-39 years old
3. Finished cancer treatment with curative intent 1 month to 5 years prior to enrollment (except hormone therapy)
4. NED and no anticipated/scheduled anti-cancer treatments at the time of enrollment (except hormone therapy)
5. Able to speak and read English
6. Able and willing to give informed consent
7. Access to internet or cellular connectivity with sufficient bandwidth to participate in videoconferences (Part 2 only)

Exclusion Criteria

1. Ongoing or future anti-cancer treatments (beyond hormone therapy) are scheduled or anticipated
2. Documented or observable psychiatric or neurological disorders that could interfere with study participation (e.g., psychosis, active substance abuse)

Vulnerable populations will not be included in this study.

Minimum Eligible Age

18 Years

Maximum Eligible Age

39 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No